Objective: Cell death plays an important role in the pathology associated with inflammatory diseases such as osteoarthritis. It has been reported that autophagy can protect cells against tumour necrosis factor-α (TNF-α)-induced apoptosis. This study aimed to determine the potential role of microRNA-30b (miR-30b) in TNF-α-induced apoptosis, autophagy and differentiation in the chondrogenic ADTC5 cell line. Methods: To analyse the effect of TNF-α on the viability of ADTC5 cells, cell counting kit-8 and Hoechst 33342 staining were employed and the expression levels of caspase-3 and -9 were assessed. Autophagy was examined by analysing the levels of LC3B-II and p62 and quantitating GFP-LC3B by fluorescence microscopy. A luciferase reporter assay investigated the putative binding sites of miR-30b. The effects of miR-30b and antimiR-30b on autophagy, apoptosis and osteogenic differentiation of TNF-α-treated cells were determined by autophagosome, apoptosis and alkaline phosphatase assays, respectively. Results: TNF-α exposure decreased cell viability, increased apoptosis and positively regulated autophagy in ADTC5 cells. A direct interaction was detected between miR-30b and the mRNA 3ʹ-UTRs of autophagy genes BECN1 and ATG5. Overexpression of miR-30b downregulated autophagy genes and upregulated pro-apoptotic gene expression in TNF-α-treated cells, while treatment with antimiR-30b had the inverse effect. Overexpression of miR-30b also downregulated ECM degradation and anti-miR-30b reverse TNF-α-induced ECM degradation. Conclusions: Anti-miR-30b enhanced autophagy and attenuated cartilage degradation and played a protective role in TNF-α-induced apoptosis of ATDC5 cells. AntimiR-30b may therefore elevate cellular survival during inflammation and has therapeutic potential for inflammatory diseases such as osteoarthritis.
Introduction
Osteoarthritis (OA) is a progressive degenerative disease that affects the joints. It results from the degradation of articular cartilage tissue and the loss of cartilage integrity, thought to be mediated by proteoglycan depletion and chondrocyte cell death [1, 2] . Chondrocytes play a key role in skeletal development and are the only cell type present in mature cartilage. The cartilage of patients with OA showed a higher proportion of apoptotic chondrocytes than normal cartilage tissue [3, 4] , indicating that chondrocyte cell death plays an important role in the pathogenesis of OA. Inflammation is also now well recognised as a contributory factor in the pathology of OA, with inflammatory cytokines, chemokines, and other inflammatory mediators produced by the synovium and chondrocytes being detected in the synovial fluids of patients [5] . In response to elevated cytokine levels, chondrocytes become activated to synthesise and secrete cartilage-degrading proteases, cytokines, and other inflammatory mediators, including interleukin 1 (IL-1) and tumour necrosis factor-α (TNF-α). IL-1 and TNF-α have been implicated to play a role in cartilage destruction [6] . Activated chondrocytes also display aberrant expression of inflammation-related genes, including catabolic genes, such as nitric oxide synthase (NOS)-2, cyclooxygenase (COX)-2, and several matrix metalloproteinases (MMPs), including MMP-13. All of these changes contribute to the pathogenesis of OA and indicate the importance of inflammation in disease progression.
Autophagy is the controlled degradation and recycling of cellular components such as damaged macromolecules and organelles [7, 8] . This process occurs at a low level in all cells to maintain homeostasis and ensure the turnover of long-lived proteins and organelles [9] . The cellular components targeted for degradation are engulfed within doublemembraned vacuoles, known as autophagosomes, and then delivered to lysosomes for proteolytic degradation, with the products being re-used in anabolic/metabolic reactions [7, 8] . Autophagy is upregulated in response to environmental stress, such as starvation or inflammation, either to protect cells and ensure survival by disposing of damaged cellular components [10] , or alternatively to induce type-2 programmed cell death or autophagic cell death [11] . The relationship between these two potential outcomes is complex and dependent of both the stress signal and the cell type [12] .
MicroRNAs (miRNAs) have been identified as potential regulators of autophagy. MiRNAs are evolutionarily conserved, endogenous, non-coding small RNAs (18-25 nucleotides in length) that negatively regulate gene expression by binding to specific target mRNAs, leading to either cleavage or translational inhibition [13] . MiRNAs bind to their target mRNAs through incomplete base-pairing to the 3ʹ-untranslated region (3ʹ-UTR) or by binding to the amino acid coding sequence [13] [14] [15] [16] [17] [18] [19] It is now believed that each miRNA is capable of modulating the expression of hundreds of target genes, thereby affecting virtually all fundamental biological pathways and playing a critical role in a broad range of biological processes including proliferation, differentiation, apoptosis, and stress responses [20, 21] . Recent findings have indicated some novel roles for miRNAs in the regulation of autophagy [22, 23] . The 3ʹ-UTR of autophagy-associated gene 12 (Atg12) was reported to contain a predicted target site for miRNA-30b (miR-30b) and this miRNA has been shown to modulate autophagy in hepatic ischemia-reperfusion injury [24] .
Here, we investigated the role of miR-30b in TNF-α-treated ATDC5 cells and assessed the potential effects of this miRNA on the cellular processes of differentiation, autophagy and apoptosis. Our findings provide valuable insight into the complex coordinated regulation of TNF-α-induced apoptosis and autophagy by miR-30b in chondrocytes, which may lead to novel therapeutic strategies for OA.
Viable cells were also visualized by fluorescent staining of DNA and nuclei with Hoechst 33342. The Hoechst 33342 stain was added at 10 μM to the cell media and incubated at 37°C for 15 min, then cells were washed three times with PBS. Morphological changes were observed using a fluorescence microscope (Olympus, Tokyo, Japan).
Detection of autophagosomes with GFP-LC3 labeling
ATDC5 cells were transfected with GFP-LC3 cDNA using Lipofectamine 2000 reagent (Invitrogen) according to the supplier's protocol and incubated for 72 h. Next, the supernatants were removed and replaced with fresh media. The cells were then subject to further assays and co-transfected with miRNAs when appropriate. Cells were subsequently subjected to starvation in serum-free Hank's balanced salt solution (HBSS). GFP-LC3-labeled vacuoles (autophagosomes) were counted under a fluorescence microscope (Olympus IX70).
Detection of autophagosomes with GFP-LC3 labelling
ATDC5 cells at 80% confluence were transfected with GFP-LC3B-expressing plasmid using Lipofectamine 2000 reagent (Invitrogen) according to standard methods. The punctate patterns of LC3B in transfected cells were examined and quantitated using a fluorescence microscope (Olympus) for at least 200 cells and the number of autophagosomes was recorded.
Transfection of cells with miRNAs
Synthetic miR-30b mimics, antimiR-30b, miR-NC and antimiR-NC, were purchased from Invitrogen. Cells were transfected with miRNAs using Lipofectamine 2000 reagent (Invitrogen) according to standard methods.
Luciferase reporter assay
Putative miR-30b binding sites in the 3ʹ-UTRs of BECN1 and ATG5 mRNAs were predicted using miRanda-mirsVR (http://www.microrna.org/microrna/home.do). A fragment containing the putative miR30b binding site was amplified and subcloned into the pGL3 plasmid to generate the pGL3-BECN1 and pGL3-ATG5 3ʹ-UTR-wild type. The respective putative binding sites were mutated and wild-type or mutated BECN1 or ATG5 3ʹ-UTR reporter plasmids (BECN1-WT or ATG5-WT, or BECN1-Mut or ATG5-Mut) were co-transfected with miR-30b or nonspecific control microRNA (NC) (Invitrogen) into ATDC5 cells and the fluorescence intensity was measured.
RT-PCR
The following sets of primers were used for reverse transcription and amplification of genes by PCR: Aggrecan 5'-CCACTGGAGAGGACTGCGTAG-3' and 5'-GGTCTGTGCAAGTGATTCGAG-3'; Col2A:
5ʹ-CCCGCCTTCCCATTATTGAC-3ʹ and 5'-GGGAGGACGGTTGGGTATCA-3'; SOX9:
5ʹ-GACTTCCGCGACGTGGA C-3ʹ and 5ʹ-GTTGGGCGGCAGGTACTG-3ʹ; MMP13: 5ʹ-ATGCATTCAGCTATCCT GGCCA-3ʹ and 5ʹ-AAGATTGCATTTCTCGGAGCCTG-3ʹ; MMP2: 5'-GAATGCCA TCCCTGATAACCT-3'; and 5'-GCTTCCAAACTTCACGCTCT-3'; ADAMTS1: 5'-GGCAAACGAGTCCGCTAC-3' and 5'-CCCACTCTTCAATCACCCAC-3'; ADAMTS4: 5'-TGCCAGCGGTCAAGGTCCCA-3' and 5'-AGGTAGCGCTTTAG CCCCGA-3'; TIMP1: 5'-CCTTCTGCAATTCCGACCTC-3' and 5'-CGGGCAGGA TTCAGGCTAT-3' TIMP3: 5'-GCGGAAGCGTGCACATG-3' and 5'-GCTTCTTT CCCACCACTTTGG-3' GAPDH: 5ʹ-TGACCACAGTCCATGCCATC-3ʹ and 5ʹ-GAC GGACACATTGGGGGTAG-3ʹ. For RT-PCR, a SYBR green qPCR SuperMix-UDG kit (Life Technologies, Gaithersburg, MD, USA) was used, along with the appropriate template, and cycling was performed using an ABI PRISM 7300 system (Applied Biosystems, Foster City, CA, USA).
Western blot analysis
Western blot analysis was performed using standard procedures. Primary antibodies included anticaspase 3 and anti-caspase 9 antibodies (Abcam, Cambridge, MA, USA), and anti-ATG5, anti-BECN1, anti-LC3 and anti-P62 antibodies (Santa Cruz Biotechnology, Santa Cruz, CA, USA). Horseradish peroxidaseconjugated secondary antibodies were used and specific antibody-antigen complexes were detected using a chemiluminescent substrate.
Statistical analysis
Experiments were performed at least in triplicate and data are expressed as the mean ± standard deviation (SD). For statistical analysis, data were analysed using the Student's t test. P values < 0.05 were considered statistically significant.One-way ANOVA was used for comparison among the different groups.
Results

Decreased cell viability and increased apoptosis in response to TNF-α exposure of ATDC5
cells TNF-α is an inflammatory cytokine reported to induce cellular apoptosis. Cell death was examined in TNF-α-treated ADTC5 cells using the Cell Counting Kit-8 (Fig. 1A) . Cell viability, as indicated by the absorbance at OD 450 , decreased significantly after exposure to higher concentrations of TNF-α (10 or 20 ng/mL; P < 0.01, at 12, 24 and 48 h). Hoechst 33342 staining of live cells confirmed these findings, with a significantly diminished number of viable cells at higher TNF-α concentrations (10 or 20 ng/mL; P < 0.01; Fig. 1B) . Also, chromatin condensation and fragmentation characteristic of apoptosis was observed in TNF-α-treated cells.
To assess the effects of TNF-α exposure on apoptosis of ADTC5 cells, the expression levels of the apoptotic indicators caspase-3 and caspase-9 were analysed by western blotting in TNF-α-treated cells (Fig. 1C) . Densitometric analysis of the protein bands revealed increased expression of caspase 3 and caspase 9 over a 24-h time course (6 h, P < 0.05; 12 and 24 h, P < 0.01; Fig. 1D ). Taken together, these findings therefore confirmed that TNF-α exposure decreased cell viability and increased apoptosis in ATDC5 cells.
Changes in autophagy in TNF-α-induced ATDC5 cells
TNF-α is also thought to induce autophagy. To analyse the effects of exposure to TNF-α on the autophagic flux in ATDC5 cells, cells were transfected with GFP-LC3B-expressing plasmid and treated with TNF-α, Rap (an activator of autophagy) or 3-MA (an inhibitor of autophagy) ( Fig. 2A) . Autophagosome formation, as indicated by GFP-labelled puncta under a fluorescence microscope, was significantly increased after treatment with Rap and decreased after treatment with 3-MA (P < 0.01), compared with control cells, confirming the validity of the assay. In TNF-α-treated cells, autophagosome formation was found to be increased (P < 0.05), indicating that TNF-α may positively regulate autophagy in these cells.
Autophagy was further assessed by western blot analysis of the expression of autophagy genes BECN1, ATG5 and LC3B-II, and the autophagic degradation target p62, in cells treated with TNF-α, Rap or 3-MA, as shown in Fig. 2B . Densitometric analysis of the protein
MiR-30b directly targets BECN1 and ATG5
MiRNAs have been identified as potential regulators of autophagy. Here, a putative miR-30b binding site was detected within the 3ʹ-UTR of the BECN1 and ATG5 mRNAs, as indicated in Fig. 3A . To determine whether a direct interaction occurs between miR-30b and its putative binding sites in the 3ʹ-UTRs of BECN1 and ATG5 mRNA a luciferase reporter Western blot analysis of the expression of cleaved caspase 3 and cleaved caspase 9 in cells exposed to TNF-α (20 ng/ml) for 6, 12 or 24 h. Control cells cultured in the absence of TNF-α for 24 h were included. GAPDH expression was detected as an endogenous control; D. Quantification of the western blot data by densitometric analysis. All data are presented as the mean ± SD from three independent replicate experiments. *P < 0.05, **P < 0.01 vs. control, untreated cells. assay was performed. The respective putative binding sites were mutated and wild-type or mutated BECN1 or ATG5 3ʹ-UTR reporter plasmids (BECN1-WT or ATG5-WT, or BECN1-Mut or ATG5-Mut) were co-transfected with miR-30b or nonspecific control microRNA (NC) into ATDC5 cells and the fluorescence intensity was measured (Fig. 3B) . The findings confirmed the direct interaction between miR-30b and its putative binding site in the 3ʹ-UTR of BECN1 and ATG5 mRNAs. When the wild-type BECN1 or ATG5 3ʹ-UTR reporter plasmids were cotransfected with miR-30b a significant reduction in fluorescence was detected (P < 0.01), indicating that overexpression of miR-30b suppressed the activity of the reporter construct containing the 3ʹ-UTR and inhibited BECN1 and ATG5 expression in TNF-α-treated ATDC5 cells. This implied a direct interaction between the identified binding sites in BECN1 and ATG5 mRNA and miR-30b.
This finding was further confirmed by RT-PCR analysis of BECN1 and ATG5 mRNA expression levels, showing reduced expression in the presence of miR-30b and elevated expression in the presence of antimiR-30b compared with control cells (P < 0.01; Fig. 3C ). Similar results were obtained at the protein level, as determined by western blot analysis (Fig. 3D) , implying that miR-30b has a modulatory effect of autophagy gene expression.
MiR-30b downregulates TNF-α-induced autophagy and the expression of autophagy genes in ATDC5 cells
To investigate the effects of miR-30b on autophagy of TNF-α-treated ATDC5 cells, cells were transfected with GFP-LC3B-expressing plasmid and treated with TNF-α. Cells were 
AntimiR-30b repressed TNF-α-induced apoptosis by enhancing autophagy
Since TNF-α has been shown to induce both autophagy and apoptosis in some cell types, and miRNAs are potential regulators of both of these processes, the effects of miR-30b and antimiR-30b on TNF-α-induced apoptosis of ATDC5 cells were next investigated. TNF-α-induced cells were either treated with Rap or 3-MA, or transfected with miR-NC, miR-30b, antimiR-NC or antimiR-30b, and an apoptosis assay was performed (Fig. 5A) . Importantly, TNF-α induced apoptosis in ATDC5 cells compared with untreated cells (P < 0.01). Treatment with the inducer of autophagy Rap decreased the apoptotic index, whereas the autophagy suppressor 3-MA increased the apoptotic index, potentially indicating the inverse relationship between autophagy and apoptosis in these cells. Consistent with this, miR-30b acted as an inducer of apoptosis in TNF-α-treated cells, with antimiR-30b suppressing apoptosis compared with control cells (P < 0.01). Western blot analysis of cleaved caspase 3 and 9 expression levels confirmed the upregulation of these two pro-apoptotic proteins in TNF-α-treated cells in which miR-30b was overexpressed, and downregulation when antimiR30b was overexpressed (P < 0.01; Fig. 5B and C) . MiR-30b may therefore play an important role in regulating cellular homeostasis in TNF-α-induced ATDC5 cells by orchestrating the balance between autophagic and apoptotic processes.
AntimiR-30b effected TNF-α-induced ECM degradation by enhancing autophagy
To investigate the role of TNF-α in ECM degradation of ATDC5 cells, the mRNA level of ACAN, Col2A, sox9 and MMP13 were detected by real-time RT-PCR. The results shown that compared with the control cells, the mRNA levels of ACAN, Col2A and sox9 were significant The data are presented as the mean ± SD from three independent replicate experiments. **P < 0.01 vs. control. downregulated and MMP13 was upregulated in TNF-α-treated ATDC5 cells (Fig. 6A) . This finding confirmed the potentially related effects of TNF-α on ECM degradation.
The effects of miR-30b and antimiR-30b on TNF-α-induced (20 ng/ml) ECM degradation were then assessed by real-time RT-PCR. Overexpression of miR-30b significant downregulated the mRNA levels of ACAN, Col2A and sox9 and significant upregulated the mRNA levels of MMP13, but opposite results were found in anti-miR-30b-treated cells compared with control cells (P < 0.05, Fig. 6B ). Furthermore, we treated ATDC5 cells with or without autophagy inhibitor (3-MA) 12h before miRNA transfection. In the presence of 3-MA the mRNA levels of ACAN, Col2A and sox9 was significant downregulated and the mRNA levels of MMP13 significant upregulated compared with the absence of 3-MA. 3-MA was able to block the effects of antimiR-30b (P < 0.05, Fig. 6C ). The finding suggested that the potentially related effects of anti-miR-30b on autophagy. Autophagy is regulated during aging and osteoarthritis development suggesting that autophagy is involved in these processes. We also assessed the consequence of antimiR-30b on cartilage matrix production by measuring expression of the catabolic factors MMP2, ADAMTS-1 and ADAMTS-4 and the matrix metalloproteinases inhibitors TIMP-1 and TIMP-3. Relative mRNA levels were reduced in MMP2 (P < 0.05) and ADAMTS-4 (P < 0.001) whereas they were increased in TIMP-1 (P < 0.001) and TIMP-3 (P < 0.001). Further supporting the role of antimiR-30b in attenuated cartilage degradation. All of these results demonstrate that the positive effect of anti-miR-30b on TNF-α-induced ECM degradation may be related to the effects of this antimiR on upregulating autophagy. ## P < 0.01 vs. control (no treatment). B. ATDC5 cells treated with 20 ng/mL TNF-α and transfected with miR-NC, miR-30b, antimiR-NC or antimiR-30b, were subjected to western blot analysis to analyse the expression of cleaved caspase 3 and 9. NAPDH expression was also analysed as an endogenous control. C. Quantitative analysis of the western blot data showing the relative protein expression levels. The data are presented as the mean ± SD from three independent replicate experiments. **P < 0.01 vs. control.
Discussion
It has been suggested that autophagy plays a role in the onset of OA, the most common aging-related joint pathology [25, 26] . Aging is an important risk factor for the development of OA and is associated with the progressive accumulation of damaged macromolecules and organelles in somatic cells [27] , potentially mediated by downregulation of the autophagic disposal of such damaged cellular components [28] . Autophagy-related proteins unc-51-like autophagy activating kinase 1 (ULK1), Beclin1 and microtubule-associated protein 1A/1B-light chain 3 (LC3) are reported to be expressed at high levels in healthy human cartilage [25, 29, 30] , however, their expression decreases during OA [25, 26] . Mechanistic target of rapamycin complex 1 (mTORC1) intracellular signalling pathway is an autophagic regulator that when inhibited activates the process of autophagy [31] . Inhibition of mTORC1 was reported to protect against surgery-induced OA in mice [26, 32] . Taken together, these findings confirmed the role of autophagy in the development of OA.
High levels of pro-inflammatory cytokines, such as IL-1, TNF-α, trigger apoptotic cell death under inflammatory conditions. Chondrocytes from the cartilage of OA patients have been shown to undergo increased levels of apoptotic cell death compared with normal cartilage [3, 4] . Furthermore, Lotz et al. showed that chondrocyte apoptosis was linked with proteoglycan depletion, the levels of nitric oxide production and the severity of OA [33] . In other cell types, autophagy has been shown to be induced in TNF-α-treated cells along with apoptosis [13] [14] [15] . Furthermore, autophagy has been shown to exert a protective effect against TNF-α-induced apoptosis [18] . However, the mechanisms responsible for regulating these cellular processes remain to be fully evaluated.
In recent studies, miRNAs have been reported to play a role in the regulation of autophagy [22, 23] . For example, miR-30b, for which a predicted target site resides in the 3ʹ-UTR of autophagy-associated gene 12 (Atg12), has been shown to modulate autophagy in hepatic ischemia-reperfusion injury [24] . The current study aimed to determine the potential role of miR-30b in TNF-α-induced apoptosis, autophagy and differentiation in the ATDC5 chondrogenic cell line. Predicted target sites for miR-30b were detected in the 3ʹ-UTRs of autophagy genes BECN1 and ATG5, which encode major regulators of the autophagy pathway. Beclin1 forms a complex with type III phosphatidylinositol 3-kinase and Vps34 that allows nucleation of the autophagic vesicle [34] . The Atg genes, including ATG5, play a role in the induction and nucleation of autophagic vesicles and their expansion and fusion with lysosomes, allowing enzymatic degradation and recycling [35, 36] . Our findings revealed that overexpression of miR-30b downregulated the expression of autophagy genes, upregulated pro-apoptotic gene expression and downregulated cartilage-specific extracellular matrix markers in TNF-α-induced cells. This provided evidence that miR-30b regulates TNF-α-induced apoptosis and effects TNF-α-induced ECM degradation by enhancing autophagy.
Anti-miRNA drugs represent a promising new area of therapeutics. In the current study, antimiR-30b was found to enhance autophagy and enhance expression of Sox9, collagen type II and aggrecan and playing a protective role against TNF-α-induced apoptosis of ATDC5 cells. Anti-miR-30b oligonucleotides may therefore represent a novel strategy by which to elevate cellular survival during inflammatory diseases such as OA.
